Hemab Therapeutics Holdings
COAG
39.29
-0.57
-1.43%
Hemab Therapeutics Holdings
US · COAG
#3007 by market cap
Listed 2026
39.29
-0.57
-1.43%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 5 analysts
Buy
Avg price target 64.00 +62.9%
Price target rangecurrent 39.29
Low56.00
Avg64.00
High70.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (19)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Evercore | -- | Buy | 65.00 |
| 2026-11-09 | LifeSci Capital | -- | Buy | 65.00 |
| 2026-11-05 | Wedbush | -- | Buy | 64.00 |
| 2026-10-15 | J.P. Morgan | -- | Buy | 70.00 |
| 2026-10-12 | Rodman & Renshaw | -- | Buy | 56.00 |
| 2026-08-12 | Wedbush | -- | Buy | 64.00 |
| 2026-08-11 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-07-13 | Wedbush | -- | Buy | 55.00 |
| 2026-07-13 | Jefferies | -- | Buy | 47.00 |
| 2026-07-13 | Goldman Sachs | -- | Buy | 46.00 |
| 2026-07-13 | H.C. Wainwright | -- | Buy | 52.00 |
| 2026-06-29 | Wedbush | -- | Buy | 42.00 |
| 2026-06-26 | H.C. Wainwright | -- | Buy | 40.00 |
| 2026-06-17 | H.C. Wainwright | -- | Buy | 40.00 |
| 2026-06-08 | Jefferies | -- | Buy | 39.00 |
| 2026-05-26 | Wedbush | -- | Buy | 42.00 |
| 2026-05-26 | Jefferies | -- | Buy | 39.00 |
| 2026-05-26 | Evercore | -- | Buy | 50.00 |
| 2026-05-26 | Goldman Sachs | -- | Buy | 36.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Hemab Therapeutics Holdings discussion 0 comments